Brazil vs Ireland: Previously treated cases tested for RR-/MDR-TB
Brazil
72.0%
in 2024
Ireland
71.0%
in 2024
Brazil rank
128th
Ireland rank
130th
Previously treated cases tested for RR-/MDR-TB over time
- Brazil
- Ireland
How they compare
Brazil currently reports 72.0% against 71.0% in Ireland, a difference of 1.0%.
The two have swapped places 2 times across 16 shared years of data; in 2005 it was Brazil ahead.
Brazil ranks 128th and Ireland ranks 130th of 180 countries.
Across the 3 decades both report, Brazil averaged higher in 1 and Ireland in 2.
Head to head by decade
| Decade | Brazil | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.8% | 27.0% | 6.8% | Brazil |
| 2010s | 26.9% | 65.2% | 38.3% | Ireland |
| 2020s | 69.4% | 78.4% | 9.0% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Brazil or Ireland?
- Brazil, at 72.0% against 71.0% in Ireland as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Brazil and Ireland?
- 1.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Ireland?
- 16 years are reported by both, from 2005 to 2024.
- How do Brazil and Ireland rank globally for previously treated cases tested for rr-/mdr-tb?
- Brazil ranks 128th and Ireland ranks 130th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.